Loading clinical trials...
Loading clinical trials...
A Phase I Trial of CD19 Targeted ICAR19 T Cells in Patients With CD19+ Leukemia and Lymphoma.
Conditions
Interventions
ICAR19 CAR-T cells
Locations
1
China
Weifang People's Hospital
Weifang, Shandong, China
Start Date
March 1, 2017
Primary Completion Date
December 31, 2020
Completion Date
December 31, 2025
Last Updated
December 27, 2017
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
Immune Cell, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions